Literature DB >> 43550

Normal prolactin responses in tardive dyskinesia.

G M Asnis, E J Sachar, G Langer, F S Halpern, M Fink.   

Abstract

Tardive dyskinesia has been hypothesized to be caused by a neuroleptic-induced dopamine hypersensitivity in the nigrostriatal system. This study evaluated with dopamine antagonists the possibility that such dopamine hypersensitivity extends to the tuberoinfundibular dopamine (TIDA) system, which regulates, by inhibition, pituitary prolactin secretion. Plasma prolactin concentrations in six patients with tardive dyskinesia were assessed in four conditions: During chronic haloperidol therapy; serially after abrupt haloperidol withdrawal; while unmediated; and in response to an acute dose of 0.5 mg IM haloperidol. In all four conditions, prolactin responses did not differ from those observed in normal subjects and schizophrenic patients without tardive dyskinesia. It is concluded that there is no evidence for post-synaptic dopamine hypersensitivity in the TIDA-pituitary pathway in patients with tardive dyskinesia, consistent with other reports assessing hormonal responses to dopamine agonists in such cases. It is further suggested that neuroleptic-induced dopamine hypersensitivity does not occur in the TIDA-pituitary system in humans, since it was not manifest in these tardive dyskinesia patients who would be thought particularly prone to develop it.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 43550     DOI: 10.1007/bf00428314

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  16 in total

1.  A neuroendocrine study of supersensitivity in tardive dyskinesia.

Authors:  C A Tamminga; R C Smith; G Pandey; L A Frohman; J M Davis
Journal:  Arch Gen Psychiatry       Date:  1977-10

Review 2.  Dopaminergic supersensitivity after neuroleptics: time-course and specificity.

Authors:  P Muller; P Seeman
Journal:  Psychopharmacology (Berl)       Date:  1978-12-15       Impact factor: 4.530

3.  Prolactin responses to neuroleptics in normal and schizophrenic subjects.

Authors:  P H Gruen; E J Sachar; G Langer; N Altman; M Leifer; A Frantz; F S Halpern
Journal:  Arch Gen Psychiatry       Date:  1978-01

Review 4.  Prolactin.

Authors:  A G Frantz
Journal:  N Engl J Med       Date:  1978-01-26       Impact factor: 91.245

5.  Serum prolactin levels in unmedicated schizophrenic patients.

Authors:  H Y Meltzer; E J Sachar; A G Frantz
Journal:  Arch Gen Psychiatry       Date:  1974-10

6.  A homologous radioimmunoassay for human prolactin.

Authors:  Y N Sinha; F W Selby; U J Lewis; W P VanderLaan
Journal:  J Clin Endocrinol Metab       Date:  1973-03       Impact factor: 5.958

7.  Dopamine and schizophrenia.

Authors:  H Y Meltzer; D J Goode; V S Fang; P Schyve; M Young
Journal:  Lancet       Date:  1976-11-20       Impact factor: 79.321

8.  Effects of dopamine agonists in tardive dyskinesia.

Authors:  R C Smith; C A Tamminga; J Haraszti; G N Pandey; J M Davis
Journal:  Am J Psychiatry       Date:  1977-07       Impact factor: 18.112

9.  Behavioral and neuroendocrine effects of low dose ET-495: antagonism by haloperidol.

Authors:  B Angrist; M Ain; J Rotrosen; S Gershon; F S Halpern; E J Sachar
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

10.  Postsynaptic supersensitivity in schizophrenia.

Authors:  G N Pandey; D L Garver; C Tamminga; S Ericksen; S I Ali; J M Davis
Journal:  Am J Psychiatry       Date:  1977-05       Impact factor: 18.112

View more
  3 in total

1.  3H-spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms.

Authors:  J Kornhuber; P Riederer; G P Reynolds; H Beckmann; K Jellinger; E Gabriel
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

Review 2.  Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.

Authors:  Hanna Bergman; John Rathbone; Vivek Agarwal; Karla Soares-Weiser
Journal:  Cochrane Database Syst Rev       Date:  2018-02-06

Review 3.  Prolactin and psychopathology in schizophrenia: a literature review and reappraisal.

Authors:  Ravi Philip Rajkumar
Journal:  Schizophr Res Treatment       Date:  2014-03-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.